|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
04-3536131
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(IRS Employer Identification No.)
|
45 First Avenue
|
|
Waltham, Massachusetts
|
02451
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
Common stock, $.001 par value per share
|
TGEN
|
NASDAQ Capital Market
|
|
Item 1A.
|
Risk Factors.
|
|
Item 1B.
|
Unresolved Staff Comments.
|
|
Item 2.
|
Properties.
|
|
Item 3.
|
Legal Proceedings.
|
|
Item 4.
|
Mine Safety Disclosures.
|
|
|
|
|
PART II
|
||
|
|
|
Item 5.
|
Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
|
Item 6.
|
Selected Financial Data.
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
|
Item 8.
|
Financial Statements and Supplementary Data.
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
|
|
Item 9A.
|
Controls and Procedures.
|
|
Item 9B.
|
Other Information.
|
|
|
|
|
PART III
|
||
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance.
|
|
Item 11.
|
Executive Compensation.
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence.
|
|
Item 14.
|
Principal Accounting Fees and Services.
|
|
|
|
|
PART IV
|
||
|
|
|
Item 15.
|
Exhibits and Financial Statement Schedules.
|
|
Item 16.
|
Form 10-K Summary.
|
|
|
|
|
SIGNATURES
|
|
•
|
our Products and Services segment, which designs, manufactures and sells industrial and commercial cogeneration systems at our customers’ facilities; and
|
•
|
our Energy Production segment which sells energy in the form of electricity, heat, hot water and cooling to our customers under long-term sales agreements we enter into with customers.
|
1.
|
Third-party laboratory verification. The AVL California Technology Center, a long-standing research and technology partner with the international automotive industry, confirmed our results in their state-of-the-art dynamometer test cell, which was outfitted with sophisticated emissions measurement equipment.
|
2.
|
Verifying longevity and reliability in the field. By equipping one of our 75 kW units, already operating at a customer location in Southern California with the Ultera® low-emissions technology and a device to continuously monitor emissions we verified longevity and reliability. The Ultera low-emissions system operated successfully for more than 25,000 hours, approximately 3.5 years, and consistently complied with California’s stringent emission standards over the entire field testing period.
|
3.
|
Additional independent tests. During the field test, two companies licensed in California to test emissions each verified our results at different times. The results from one of these tests, obtained in August 2011, enabled us to qualify for New Jersey’s fast-track permitting. Virtually every state nationwide requires some kind of permit related to local air quality, but New Jersey allows an exemption for systems such as ours that demonstrate superior emissions performance. This certification was granted in November 2011, and since then we have sold Ultera® low-emissions systems to customers in this territory.
|
•
|
commercial and industrial natural gas fueled engines from other manufacturers;
|
•
|
natural gas and biogas powered vehicle fleets - such as municipal bus fleets; and
|
•
|
gensets for non-emergency applications such as forced utility outages for fire safety.
|
•
|
Provide power when a utility grid is not available or goes out of service;
|
•
|
Reduce the customer’s total cost of purchasing electricity and other fuel;
|
•
|
Reduce emissions of criteria pollutants (NOx and CO) to near-zero levels and cut the emission of greenhouse gases such as carbon dioxide;
|
•
|
Provide reliable on-site power generation, heating and cooling services; and
|
•
|
Control maintenance costs and ensure optimal peak equipment performance.
|
•
|
Sacramento Municipal Utility District has provided test sites for the Company since 2010.
|
•
|
Southern California Gas Company and San Diego Gas & Electric Company, each a Sempra Energy subsidiary, have granted us research and development contracts since 2004.
|
•
|
Department of Energy’s Lawrence Berkeley National Laboratory, with which the Company has had research and development contracts since 2005, including ongoing Microgrid development work related to the InVerde.
|
•
|
Eastern Municipal Water District in Southern California has co-sponsored demonstration projects to retrofit both a natural-gas powered municipal water pump engine and a biofuel powered pumping station engine with the Ultera low emissions technology since 2012.
|
•
|
Consortium for Electric Reliability Technology Solutions executed research and development contracts with the Company, and provided a test site to the Company since 2005.
|
•
|
California Energy Commission executed research and development contracts with the Company from 2004 until March 2013.
|
•
|
The AVL California Technology Center performed a support role in research and development contracts as well as internal research and development on our Ultera emission control system from August 2009 to November 2011. In addition, the Center supported our research on emissions from gasoline vehicles from January of 2016 through October 2017. AVL researchers collaborated with our engineers on several peer reviewed papers published by technology association SAE International in 2017 and 2018.
|
•
|
Propane Education & Research Council (PERC) executed research and development contracts with the Company for work related to developing Ultera low emissions control systems for the propane powered fork truck market, now continuing with Mitsubishi Caterpillar Forklift America.
|
•
|
The Southwest Research Institute, a non-profit independent research center located in San Antonio, Texas, has been engaged by the Company to complete the next phase of research in the Ultera automotive application. This effort will focus on evaluation of advanced catalyst formulations tailored to the Ultera process and is ongoing.
|
•
|
9,995,195: “Emissions control systems and methods for vehicles.” This patent, granted in June 2018, is a method for vehicle cold start to enhance the removal of CO and hydrocarbons emissions, which are extremely problematic for cold engines. Air is injected in the exhaust between the engine’s close-coupled catalyst and underbody catalyst. Once the engine is warmed (> 500 F exhaust) this air stream is shut off. This method synergizes well with the Ultera system by utilizing the injection air feed for an alternative purpose during engine start.
|
•
|
9,956,526: “Poison-Resistant Catalyst and Systems Containing Same.” This patent, granted in May 2018, relates to a special catalyst formulation that is resistant to contaminant induced corrosion in conditions like those of the Ultera second stage. These poisons or contaminants are most commonly sulfur compounds.
|
•
|
9,702,306: “Internal Combustion Engine Controller.” This patent granted in July of 2017 relates to the unique control methodology used in the InVerde e+ CHP unit that maximizes engine fuel economy under variable speed operation.
|
•
|
9,470,126: "Assembly and method for reducing ammonia in exhaust of internal combustion engines." This patent, granted in October 2016, is related to the Ultera emission control system applicable to all our products.
|
•
|
9,856,767: “Systems and methods for reducing emissions in exhaust of vehicles and producing electricity." This patent, filed in November 2015 and published in March 2016, relates to the development of the Ultera emission control system for vehicle applications.
|
•
|
9,121,326: “Assembly and method for reducing nitrogen oxides, carbon monoxide and hydrocarbons in exhausts of internal combustion engines.” This patent, granted in September 2015, is related to the Ultera emission control system applicable to all our products.
|
•
|
8,829,698: “Power generation systems.” This patent, granted in September 2014, is for a power generation system that includes an internal combustion engine configured to provide rotational mechanical energy.
|
•
|
8,578,704: “Assembly and method for reducing nitrogen oxides, carbon monoxide, and hydrocarbons in exhausts of internal combustion engines.” This patent, granted in November 2013, is for the Ultera emission control system applicable to all our products.
|
•
|
7,243,017: “Method for controlling internal combustion engine emissions.” This patent, granted in July 2007, applies to the specific algorithms used in our engine controller for metering fuel usage to obtain the correct combustion mixture and is technology used by most of our engines.
|
•
|
7,239,034: “Engine driven power inverter system with cogeneration.” This patent, granted in July 2007, pertains to the utilization of an engine-driven CHP module combined with an inverter and applies to our InVerde product specifically.
|
•
|
“Emissions Control Systems and Methods for Vehicles.” This application filed in April 2016 relates to emissions control systems for vehicles.
|
•
|
"Assemblies and Methods for Reducing Particulate Matter, Hydrocarbons, and Gaseous Oxides from Internal Combustion Engine Exhaust." This application filed in February 2017 relates to emissions controls system for vehicles.
|
•
|
"Dual Stage Internal Combustion Engine Aftertreatment System Using Exhaust Gas Intercooling and Charger-Driven Air Ejector." This application filed in February 2017 relates to emissions controls systems for vehicles.
|
•
|
product safety certifications and interconnection requirements;
|
•
|
air pollution regulations which govern the emissions allowed in engine exhaust;
|
•
|
state and federal incentives for CHP technology;
|
•
|
various local building and permitting codes and third-party certifications;
|
•
|
electric utility pricing and related regulations; and
|
•
|
federal and state laws regarding the legalization of cannabis for medicinal and recreational use.
|
•
|
results and timing of our product development;
|
•
|
results of the development of our competitors’ products;
|
•
|
regulatory actions with respect to our products or our competitors’ products;
|
•
|
actual or anticipated fluctuations in our financial condition and operating results;
|
•
|
actual or anticipated changes in our growth rate relative to our competitors;
|
•
|
actual or anticipated fluctuations in our competitors’ operating results or changes in their growth rate;
|
•
|
competition from existing products or new products that may emerge;
|
•
|
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations, or capital commitments;
|
•
|
issuance of new or updated research or reports by securities analysts;
|
•
|
fluctuations in the valuation of companies perceived by investors to be comparable to us;
|
•
|
share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;
|
•
|
additions or departures of key management or personnel;
|
•
|
disputes or other developments related to proprietary rights, including patents, litigation matters, and our ability to obtain, maintain, defend or enforce proprietary rights relating to our products and technologies;
|
•
|
announcement or expectation of additional financing efforts;
|
•
|
sales of our Common Stock by us, our insiders, or our other stockholders; and
|
•
|
general economic and market conditions.
|
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
Weighted-average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in first column)
|
||||
Equity compensation plans approved by security holders
|
|
1,292,968
|
|
|
$
|
3.57
|
|
|
1,906,180
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
|
|
1,292,968
|
|
|
$
|
3.57
|
|
|
1,906,180
|
|
•
|
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
|
•
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles;
|
•
|
provide reasonable assurance that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
|
•
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.
|
(a)
|
Index to Financial Statements and Financial Statement Schedules
|
(b)
|
Exhibits
|
Exhibit Number
|
Description
|
|
2.1
|
||
2.2
|
||
3.1
|
||
3.2
|
||
4.1
|
||
4.3+
|
||
4.4*
|
||
10.1+
|
||
10.7
|
||
10.8
|
||
10.13#
|
||
10.24
|
||
10.29
|
||
10.30
|
||
10.38
|
||
10.42+
|
||
10.43
|
||
10.44
|
||
10.45
|
||
10.46
|
||
10.47*
|
10.48
|
||
10.49
|
||
10.50
|
||
10.51
|
||
10.52
|
||
10.53
|
||
10.54
|
||
10.55
|
||
21.1*
|
||
23.1*
|
||
31.1*
|
||
31.2*
|
||
32.1*
|
||
101.INS*
|
XBRL Instance Document
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
|
*
|
Filed herewith.
|
|
#
|
Confidential Treatment has been granted for portions of this document. The confidential portions were omitted and filed separately, on a confidential basis, with the Securities and Exchange Commission.
|
|
+
|
Management contract or compensatory plan or agreement.
|
|
TECOGEN INC.
|
|
|
(Registrant)
|
|
|
|
|
Dated: 3/12/2020
|
By:
|
/s/ Benjamin M. Locke
|
|
Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
|
|
|
|
Dated: 3/12/2020
|
By:
|
/s/ Bonnie J. Brown
|
|
Chief Accounting Officer and Treasurer
|
|
|
(Principal Accounting Officer)
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Angelina M. Galiteva
|
|
Director, Chairman of the Board
|
|
March 12, 2020
|
Angelina M. Galiteva
|
|
|
|
|
|
|
|
|
|
/s/ John N. Hatsopoulos
|
|
Lead Director
|
|
March 12, 2020
|
John N. Hatsopoulos
|
|
|
|
|
|
|
|
|
|
/s/ Benjamin M. Locke
|
|
Director and Chief Executive Officer
|
|
March 12, 2020
|
Benjamin M. Locke
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ Bonnie J. Brown
|
|
Chief Accounting Officer and Treasurer
|
|
March 12, 2020
|
Bonnie J. Brown
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
|
/s/ Deanna Petersen
|
|
Director
|
|
March 12, 2020
|
Deanna Petersen
|
|
|
|
|
|
|
|
|
|
/s/ Ahmed F. Ghoniem
|
|
Director
|
|
March 12, 2020
|
Ahmed F. Ghoniem
|
|
|
|
|
|
|
|
|
|
/s/ Earl R. Lewis III
|
|
Director
|
|
March 12, 2020
|
Earl R. Lewis III
|
|
|
|
|
|
|
|
|
|
/s/ Laurence E. de Armada Garcia Roosevelt
|
|
Director
|
|
March 12, 2020
|
Laurence E. de Armada Garcia Roosevelt
|
|
|
|
|
|
2019
|
|
2018
|
||||
ASSETS
|
|
|
|
|
|
||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
877,676
|
|
|
$
|
272,552
|
|
Accounts receivable, net
|
14,569,397
|
|
|
14,176,452
|
|
||
Unbilled revenue
|
5,421,811
|
|
|
4,893,259
|
|
||
Inventory, net
|
6,405,229
|
|
|
6,294,862
|
|
||
Due from related party
|
—
|
|
|
9,405
|
|
||
Prepaid and other current assets
|
635,034
|
|
|
722,042
|
|
||
Total current assets
|
27,909,147
|
|
|
26,368,572
|
|
||
Property, plant and equipment, net
|
3,465,948
|
|
|
11,273,115
|
|
||
Right of use assets
|
2,173,951
|
|
|
—
|
|
||
Intangible assets, net
|
1,593,781
|
|
|
2,893,990
|
|
||
Goodwill
|
5,281,867
|
|
|
8,975,065
|
|
||
Other assets
|
691,941
|
|
|
393,651
|
|
||
TOTAL ASSETS
|
$
|
41,116,635
|
|
|
$
|
49,904,393
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Revolving line of credit, bank
|
$
|
2,402,384
|
|
|
$
|
2,009,435
|
|
Accounts payable
|
5,271,756
|
|
|
7,153,330
|
|
||
Accrued expenses
|
2,599,366
|
|
|
1,528,014
|
|
||
Deferred revenue
|
2,635,619
|
|
|
2,507,541
|
|
||
Lease obligations, current
|
536,443
|
|
|
—
|
|
||
Total current liabilities
|
13,445,568
|
|
|
13,198,320
|
|
||
Long-term liabilities:
|
|
|
|
|
|
||
Deferred revenue, net of current portion
|
145,464
|
|
|
2,375,700
|
|
||
Lease obligations, long-term
|
1,637,508
|
|
|
—
|
|
||
Unfavorable contract liability, net
|
2,534,818
|
|
|
6,292,599
|
|
||
Total liabilities
|
17,763,358
|
|
|
21,866,619
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note 11)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
|
|
||
Tecogen Inc. stockholders’ equity:
|
|
|
|
|
|
||
Common stock, $0.001 par value; 100,000,000 shares authorized; 24,849,261 and 24,824,746 issued and outstanding at December 31, 2019 and 2018, respectively
|
24,849
|
|
|
24,825
|
|
||
Additional paid-in capital
|
56,622,285
|
|
|
56,427,928
|
|
||
Accumulated deficit
|
(33,379,114
|
)
|
|
(28,670,095
|
)
|
||
Total Tecogen Inc. stockholders’ equity
|
23,268,020
|
|
|
27,782,658
|
|
||
Noncontrolling interest
|
85,257
|
|
|
255,116
|
|
||
Total stockholders’ equity
|
23,353,277
|
|
|
28,037,774
|
|
||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
41,116,635
|
|
|
$
|
49,904,393
|
|
|
2019
|
|
2018
|
||||
Revenues
|
|
|
|
|
|
||
Products
|
$
|
12,977,896
|
|
|
$
|
12,624,867
|
|
Services
|
17,307,718
|
|
|
16,859,291
|
|
||
Energy production
|
3,140,834
|
|
|
6,399,526
|
|
||
Total revenues
|
33,426,448
|
|
|
35,883,684
|
|
||
Cost of sales
|
|
|
|
|
|
||
Products
|
8,385,574
|
|
|
7,797,591
|
|
||
Services
|
10,808,142
|
|
|
10,693,077
|
|
||
Energy production
|
1,753,980
|
|
|
3,801,154
|
|
||
Total cost of sales
|
20,947,696
|
|
|
22,291,822
|
|
||
Gross profit
|
12,478,752
|
|
|
13,591,862
|
|
||
Operating expenses
|
|
|
|
|
|
||
General and administrative
|
10,380,143
|
|
|
10,790,841
|
|
||
Selling
|
2,685,200
|
|
|
2,651,128
|
|
||
Research and development
|
1,460,096
|
|
|
1,297,612
|
|
||
Gain on sale of assets
|
(1,081,304
|
)
|
|
—
|
|
||
Goodwill impairment
|
3,693,198
|
|
|
4,390,590
|
|
||
Total operating expenses
|
17,137,333
|
|
|
19,130,171
|
|
||
Loss from operations
|
(4,658,581
|
)
|
|
(5,538,309
|
)
|
||
Other income (expense)
|
|
|
|
|
|
||
Interest and other income
|
933
|
|
|
8,030
|
|
||
Interest expense
|
(101,851
|
)
|
|
(120,015
|
)
|
||
Unrealized loss on investment securities
|
(19,680
|
)
|
|
(118,084
|
)
|
||
Total other expense, net
|
(120,598
|
)
|
|
(230,069
|
)
|
||
Loss before income taxes
|
(4,779,179
|
)
|
|
(5,768,378
|
)
|
||
State income tax provision
|
15,194
|
|
|
32,748
|
|
||
Consolidated net loss
|
(4,794,373
|
)
|
|
(5,801,126
|
)
|
||
Loss attributable to the noncontrolling interest
|
85,354
|
|
|
92,594
|
|
||
Net loss attributable to Tecogen Inc.
|
$
|
(4,709,019
|
)
|
|
$
|
(5,708,532
|
)
|
|
|
|
|
||||
Net loss per share - basic and diluted
|
$
|
(0.19
|
)
|
|
$
|
(0.23
|
)
|
Weighted average shares outstanding - basic and diluted
|
24,839,957
|
|
|
24,815,926
|
|
|
|
Tecogen Inc. Stockholders
|
|
|
|
|
|||||||||||||||||||||
|
|
Common Stock Shares
|
|
Common
Stock $.001 Par Value |
|
Additional
Paid-In Capital |
|
Accumulated Other Comprehensive Loss
|
|
Accumulated
Deficit |
|
Noncontrolling
Interest |
|
Total
|
|||||||||||||
Balance at December 31, 2017
|
|
24,766,892
|
|
|
$
|
24,767
|
|
|
$
|
56,176,330
|
|
|
$
|
(165,317
|
)
|
|
$
|
(22,796,246
|
)
|
|
$
|
455,611
|
|
|
$
|
33,695,145
|
|
Exercise of stock options
|
|
57,854
|
|
|
58
|
|
|
72,867
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
72,925
|
|
||||||
Reclassification of Accumulated Other Comprehensive Loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
165,317
|
|
|
(165,317
|
)
|
|
—
|
|
|
—
|
|
||||||
Stock issuance costs
|
|
—
|
|
|
—
|
|
|
(2,457
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,457
|
)
|
||||||
Distributions to non-controlling interest
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(107,901
|
)
|
|
(107,901
|
)
|
||||||
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
181,188
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
181,188
|
|
||||||
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,708,532
|
)
|
|
(92,594
|
)
|
|
(5,801,126
|
)
|
||||||
Balance at December 31, 2018
|
|
24,824,746
|
|
|
$
|
24,825
|
|
|
$
|
56,427,928
|
|
|
$
|
—
|
|
|
$
|
(28,670,095
|
)
|
|
$
|
255,116
|
|
|
$
|
28,037,774
|
|
Exercise of stock options
|
|
24,515
|
|
|
24
|
|
|
33,593
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
33,617
|
|
||||||
Stock issuance costs
|
|
—
|
|
|
—
|
|
|
(2,700
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,700
|
)
|
||||||
Distributions to non-controlling interest
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(84,505
|
)
|
|
(84,505
|
)
|
||||||
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
163,464
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
163,464
|
|
||||||
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,709,019
|
)
|
|
(85,354
|
)
|
|
(4,794,373
|
)
|
||||||
Balance at December 31, 2019
|
|
24,849,261
|
|
|
$
|
24,849
|
|
|
$
|
56,622,285
|
|
|
$
|
—
|
|
|
$
|
(33,379,114
|
)
|
|
$
|
85,257
|
|
|
$
|
23,353,277
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
2019
|
|
2018
|
|||||
Consolidated net loss
|
$
|
(4,794,373
|
)
|
|
$
|
(5,801,126
|
)
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|||
Depreciation, accretion and amortization, net
|
437,102
|
|
|
789,123
|
|
|||
Gain on contract termination
|
—
|
|
|
(124,733
|
)
|
|||
(Gain) loss on sale of assets
|
(1,081,304
|
)
|
|
22,088
|
|
|||
Provision for losses on accounts receivable
|
48,000
|
|
|
4,395
|
|
|||
Stock-based compensation
|
163,464
|
|
|
181,188
|
|
|||
Goodwill impairment
|
3,693,198
|
|
|
4,390,590
|
|
|||
Non-cash interest expense
|
43,669
|
|
|
32,225
|
|
|||
Changes in operating assets and liabilities, net of effects of acquisition:
|
|
|
|
|
|
|||
(Increase) decrease in:
|
|
|
|
|||||
Accounts receivable
|
(440,945
|
)
|
|
(4,467,939
|
)
|
|||
Unbilled revenue
|
(528,452
|
)
|
|
(697,586
|
)
|
|||
Inventory, net
|
(110,367
|
)
|
|
(1,164,057
|
)
|
|||
Due from related party
|
9,405
|
|
|
576,087
|
|
|||
Prepaid expenses and other current assets
|
(9,545
|
)
|
|
49,484
|
|
|||
Other non-current assets
|
(298,290
|
)
|
|
113,284
|
|
|||
Increase (decrease) in:
|
|
|
|
|
|
|||
Accounts payable
|
(1,881,574
|
)
|
|
1,173,979
|
|
|||
Accrued expenses and other current liabilities
|
380,993
|
|
|
111,038
|
|
|||
Deferred revenue
|
(115,223
|
)
|
|
1,006,893
|
|
|||
Interest payable, related party
|
—
|
|
|
(52,265
|
)
|
|||
Net cash used in operating activities
|
(4,484,242
|
)
|
|
(3,857,332
|
)
|
|||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|||
Purchases of property and equipment
|
(95,643
|
)
|
|
(828,086
|
)
|
|||
Proceeds on sale of property and equipment
|
5,000,000
|
|
|
2,003,606
|
|
|||
Purchases of intangible assets
|
(110,683
|
)
|
|
(226,847
|
)
|
|||
Cash acquired in acquisition
|
—
|
|
|
442,746
|
|
|||
Expenses associated with asset acquisition
|
—
|
|
|
(2,457
|
)
|
|||
Payment of stock issuance costs
|
(2,700
|
)
|
|
—
|
|
|||
Distributions to non-controlling interest
|
(84,505
|
)
|
|
(107,901
|
)
|
|||
Net cash provided by investing activities
|
4,706,469
|
|
|
1,281,061
|
|
|||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|||
Proceeds on revolving line of credit, net of payments
|
349,280
|
|
|
2,097,837
|
|
|||
Payments for debt issuance costs
|
—
|
|
|
(145,011
|
)
|
|||
Payments made on loan due to related party
|
—
|
|
|
(850,000
|
)
|
|||
Proceeds from exercise of stock options
|
33,617
|
|
|
72,925
|
|
|||
Net cash provided by financing activities
|
382,897
|
|
|
1,175,751
|
|
|||
Change in cash and cash equivalents
|
605,124
|
|
|
(1,400,520
|
)
|
|||
Cash and cash equivalents, beginning of the year
|
272,552
|
|
|
1,673,072
|
|
|||
Cash and cash equivalents, end of the year
|
$
|
877,676
|
|
|
$
|
272,552
|
|
Cash paid for interest
|
$
|
51,888
|
|
|
$
|
140,055
|
|
Cash paid for taxes
|
$
|
35,398
|
|
|
$
|
32,748
|
|
Year Ended
|
December 31, 2019
|
||||||||||
|
Products and Services
|
|
Energy Production
|
|
Total
|
||||||
Products
|
$
|
12,977,896
|
|
|
$
|
—
|
|
|
$
|
12,977,896
|
|
Installation services
|
7,505,964
|
|
|
—
|
|
|
7,505,964
|
|
|||
Maintenance services
|
9,801,754
|
|
|
—
|
|
|
9,801,754
|
|
|||
Energy production
|
—
|
|
|
3,140,834
|
|
|
3,140,834
|
|
|||
Total revenue
|
$
|
30,285,614
|
|
|
$
|
3,140,834
|
|
|
$
|
33,426,448
|
|
Year Ended
|
December 31, 2018
|
||||||||||
|
Products and Services
|
|
Energy Production
|
|
Total
|
||||||
Products
|
12,624,867
|
|
|
$
|
—
|
|
|
$
|
12,624,867
|
|
|
Installation services
|
8,097,473
|
|
|
—
|
|
|
8,097,473
|
|
|||
Maintenance services
|
8,761,818
|
|
|
—
|
|
|
8,761,818
|
|
|||
Energy production
|
—
|
|
|
6,399,526
|
|
|
6,399,526
|
|
|||
Total revenue
|
$
|
29,484,158
|
|
|
$
|
6,399,526
|
|
|
$
|
35,883,684
|
|
|
2019
|
|
2018
|
||||
Net loss attributable to stockholders
|
$
|
(4,709,019
|
)
|
|
$
|
(5,708,532
|
)
|
Weighted average shares outstanding - Basic and diluted
|
24,839,957
|
|
|
24,815,926
|
|
||
Loss per share - Basic and diluted
|
$
|
(0.19
|
)
|
|
$
|
(0.23
|
)
|
|
|
|
|
||||
Anti-dilutive shares underlying stock options outstanding
|
142,756
|
|
|
144,077
|
|
|
2019
|
|
2018
|
||||
Raw materials, net
|
$
|
5,966,162
|
|
|
$
|
5,881,099
|
|
Work-in-process
|
439,067
|
|
|
413,763
|
|
||
Finished goods
|
—
|
|
|
—
|
|
||
|
$
|
6,405,229
|
|
|
$
|
6,294,862
|
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||||||||
Intangible assets
|
|
Cost
|
|
Accumulated Amortization
|
|
Net
|
|
Cost
|
|
Accumulated Amortization
|
|
Net
|
||||||||||||
Product certifications
|
|
$
|
726,159
|
|
|
$
|
(399,906
|
)
|
|
$
|
326,253
|
|
|
$
|
726,159
|
|
|
$
|
(345,658
|
)
|
|
$
|
380,501
|
|
Patents
|
|
1,017,108
|
|
|
(206,499
|
)
|
|
810,609
|
|
|
910,569
|
|
|
(188,239
|
)
|
|
722,330
|
|
||||||
Developed technology
|
|
240,000
|
|
|
(108,000
|
)
|
|
132,000
|
|
|
240,000
|
|
|
(92,000
|
)
|
|
148,000
|
|
||||||
Trademarks
|
|
26,896
|
|
|
—
|
|
|
26,896
|
|
|
22,752
|
|
|
—
|
|
|
22,752
|
|
||||||
In process R&D
|
|
263,936
|
|
|
—
|
|
|
263,936
|
|
|
263,936
|
|
|
—
|
|
|
263,936
|
|
||||||
TTcogen intangible assets
|
|
29,607
|
|
|
(6,477
|
)
|
|
23,130
|
|
|
29,607
|
|
|
(2,776
|
)
|
|
26,831
|
|
||||||
Favorable contract assets
|
|
274,858
|
|
|
(263,901
|
)
|
|
10,957
|
|
|
1,561,739
|
|
|
(232,099
|
)
|
|
1,329,640
|
|
||||||
|
|
$
|
2,578,564
|
|
|
$
|
(984,783
|
)
|
|
$
|
1,593,781
|
|
|
$
|
3,754,762
|
|
|
$
|
(860,772
|
)
|
|
$
|
2,893,990
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Intangible liability
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unfavorable contract liability
|
|
$
|
4,689,025
|
|
|
$
|
(2,154,207
|
)
|
|
$
|
2,534,818
|
|
|
$
|
7,912,275
|
|
|
$
|
(1,619,676
|
)
|
|
$
|
6,292,599
|
|
|
|
Non-contract related intangibles
|
|
Contract related intangibles
|
|
Total
|
||||||
2020
|
|
$
|
246,967
|
|
|
$
|
(431,990
|
)
|
|
(185,023
|
)
|
|
2021
|
|
232,266
|
|
|
(437,477
|
)
|
|
(205,211
|
)
|
|||
2022
|
|
225,556
|
|
|
(411,844
|
)
|
|
(186,288
|
)
|
|||
2023
|
|
218,368
|
|
|
(335,183
|
)
|
|
(116,815
|
)
|
|||
2024
|
|
195,961
|
|
|
(290,260
|
)
|
|
(94,299
|
)
|
|||
Thereafter
|
|
436,810
|
|
|
(617,107
|
)
|
|
(180,297
|
)
|
|||
|
|
$
|
1,555,928
|
|
|
$
|
(2,523,861
|
)
|
|
$
|
(967,933
|
)
|
|
Estimated Useful
Life (in Years)
|
|
2019
|
|
2018
|
||||
Energy systems
|
10 - 15 years
|
|
$
|
4,372,638
|
|
|
$
|
12,709,990
|
|
Machinery and equipment
|
5 - 7 years
|
|
1,462,208
|
|
|
1,355,617
|
|
||
Furniture and fixtures
|
5 years
|
|
193,698
|
|
|
222,542
|
|
||
Computer software
|
3 - 5 years
|
|
192,865
|
|
|
200,626
|
|
||
Leasehold improvements
|
*
|
|
450,792
|
|
|
450,792
|
|
||
|
|
|
6,672,201
|
|
|
14,939,567
|
|
||
Less - accumulated depreciation and amortization
|
|
|
(3,206,253
|
)
|
|
(3,666,452
|
)
|
||
Net property, plant and equipment
|
|
|
$
|
3,465,948
|
|
|
$
|
11,273,115
|
|
|
Product and Service
|
|
Energy Production
|
|
Total Company
|
||||||
Balance at December 31, 2017
|
$
|
40,870
|
|
|
$
|
13,324,785
|
|
|
$
|
13,365,655
|
|
Impairment loss
|
—
|
|
|
(4,390,590
|
)
|
|
(4,390,590
|
)
|
|||
Balance at December 31, 2018
|
40,870
|
|
|
8,934,195
|
|
|
8,975,065
|
|
|||
Impairment loss-Sale of assets, Note 5
|
—
|
|
|
(3,693,198
|
)
|
|
(3,693,198
|
)
|
|||
Balance at December 31, 2019
|
$
|
40,870
|
|
|
$
|
5,240,997
|
|
|
$
|
5,281,867
|
|
Warranty reserve, December 31, 2017
|
$
|
133,500
|
|
Warranty provision for units sold
|
348,100
|
|
|
Costs of warranty incurred
|
(341,000
|
)
|
|
Warranty reserve, December 31, 2018
|
140,600
|
|
|
Warranty provision for units sold
|
535,700
|
|
|
Costs of warranty incurred
|
(471,000
|
)
|
|
Warranty reserve, December 31, 2019
|
$
|
205,300
|
|
Cash paid for amounts included in the measurement of operating lease liabilities
|
$
|
641,290
|
|
|||
Right-of-use assets obtained in exchange for new operating lease liabilities
|
$
|
2,676,202
|
|
|||
Weighted-average remaining lease term - operating leases
|
4.0 years
|
|
||||
Weighted-average discount rate - operating leases
|
6
|
%
|
|
|
Operating Leases
|
|
|
2020
|
|
$
|
649,801
|
|
2021
|
|
576,698
|
|
|
2022
|
|
559,115
|
|
|
2023
|
|
566,863
|
|
|
2024
|
|
134,700
|
|
|
Total lease payments
|
|
2,487,177
|
|
|
Less: imputed interest
|
|
313,226
|
|
|
Total
|
|
$
|
2,173,951
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
|||||
Outstanding, December 31, 2018
|
1,292,589
|
|
|
$0.79-$10.33
|
|
$
|
3.52
|
|
|
5.93 years
|
|
$
|
671,331
|
|
Granted
|
88,500
|
|
|
$3.40-$3.80
|
|
3.70
|
|
|
|
|
|
|
||
Exercised
|
(24,515
|
)
|
|
$1.20-$2.60
|
|
1.37
|
|
|
|
|
19,794
|
|
||
Canceled and forfeited
|
(3,700
|
)
|
|
$3.22-$4.50
|
|
3.46
|
|
|
|
|
|
|
||
Outstanding, December 31, 2019
|
1,352,874
|
|
|
$0.79-$10.33
|
|
$
|
3.57
|
|
|
5.30 years
|
|
$
|
95,381
|
|
Exercisable, December 31, 2019
|
953,499
|
|
|
|
|
$
|
3.54
|
|
|
|
|
$
|
95,381
|
|
Vested and expected to vest, December 31, 2019
|
1,292,968
|
|
|
|
|
$
|
3.57
|
|
|
|
|
$
|
95,381
|
|
Stock option awards:
|
|
2019
|
|
2018
|
Expected life
|
|
6.25 years
|
|
6.25 years
|
Risk-free interest rate
|
|
2.56%
|
|
2.73%
|
Expected volatility
|
|
22.50%
|
|
20.90%
|
December 31, 2019
|
|
|
Quoted prices in active markets for identical assets
|
|
Significant other observable inputs
|
|
Significant unobservable inputs
|
|
|
||||||||||
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total losses
|
||||||||||
Recurring fair value measurements
|
|
|
|
|
|
|
|
|
|
||||||||||
Available-for-sale equity securities
|
|
|
|
|
|
|
|
|
|
||||||||||
EuroSite Power Inc.
|
$
|
216,487
|
|
|
$
|
—
|
|
|
$
|
216,487
|
|
|
$
|
—
|
|
|
$
|
(19,680
|
)
|
Total recurring fair value measurements
|
$
|
216,487
|
|
|
$
|
—
|
|
|
$
|
216,487
|
|
|
$
|
—
|
|
|
$
|
(19,680
|
)
|
December 31, 2018
|
|
|
|
|
|
|
|
|
|
||||||||||
Recurring fair value measurements
|
|
|
|
|
|
|
|
|
|
||||||||||
Available-for-sale equity securities
|
|
|
|
|
|
|
|
|
|
||||||||||
EuroSite Power Inc.
|
$
|
236,167
|
|
|
$
|
—
|
|
|
$
|
236,167
|
|
|
$
|
—
|
|
|
$
|
(283,401
|
)
|
Total recurring fair value measurements
|
$
|
236,167
|
|
|
$
|
—
|
|
|
$
|
236,167
|
|
|
$
|
—
|
|
|
$
|
(283,401
|
)
|
Cash
|
$
|
442,786
|
|
Accounts receivable
|
176,235
|
|
|
Unbilled revenue
|
232,540
|
|
|
Fixed assets
|
47,508
|
|
|
Intangible assets
|
29,607
|
|
|
Accounts payable
|
(811,468
|
)
|
|
Deferred revenue
|
(44,610
|
)
|
|
Cash payable
|
$
|
72,598
|
|
|
|
Products and Services
|
|
Energy Production
|
|
Corporate, other and elimination (1)
|
|
Total
|
||||||||
Year ended December 31, 2019
|
|
|
|
|
|
|
|
|
||||||||
Revenue - external customers
|
|
$
|
30,285,614
|
|
|
$
|
3,140,834
|
|
|
$
|
—
|
|
|
$
|
33,426,448
|
|
Intersegment revenue
|
|
609,530
|
|
|
—
|
|
|
(609,530
|
)
|
|
—
|
|
||||
Total revenue
|
|
$
|
30,895,144
|
|
|
$
|
3,140,834
|
|
|
$
|
(609,530
|
)
|
|
$
|
33,426,448
|
|
Gross profit
|
|
$
|
11,091,898
|
|
|
$
|
1,386,854
|
|
|
$
|
—
|
|
|
$
|
12,478,752
|
|
Identifiable assets
|
|
$
|
32,508,704
|
|
|
$
|
8,607,931
|
|
|
$
|
—
|
|
|
$
|
41,116,635
|
|
|
|
|
|
|
|
|
|
|
||||||||
Year ended December 31, 2018
|
|
|
|
|
|
|
|
|
||||||||
Revenue - external customers
|
|
$
|
29,484,158
|
|
|
$
|
6,399,526
|
|
|
$
|
—
|
|
|
$
|
35,883,684
|
|
Intersegment revenue
|
|
1,211,148
|
|
|
—
|
|
|
(1,211,148
|
)
|
|
—
|
|
||||
Total revenue
|
|
30,695,306
|
|
|
6,399,526
|
|
|
(1,211,148
|
)
|
|
35,883,684
|
|
||||
Gross profit
|
|
10,993,490
|
|
|
2,598,372
|
|
|
—
|
|
|
13,591,862
|
|
||||
Identifiable assets
|
|
27,566,921
|
|
|
22,337,472
|
|
|
—
|
|
|
49,904,393
|
|
|
|
|
2019
|
|
2018
|
||||
Pre-tax book income (loss)
|
|
(4,779,179
|
)
|
|
(5,768,378
|
)
|
|||
Expected tax at 21%
|
|
(1,008,353
|
)
|
|
(1,211,359
|
)
|
|||
|
|
|
|
|
|
||||
Permanent differences:
|
|
|
|
|
|||||
|
Machinery & equipment
|
|
3,728
|
|
|
4,658
|
|
||
|
Mark to market
|
|
4,133
|
|
|
24,798
|
|
||
|
Goodwill impairment
|
|
775,572
|
|
|
922,024
|
|
||
|
Intangible Amortization
|
|
(105,573
|
)
|
|
(180,780
|
)
|
||
|
Stock compensation
|
|
—
|
|
|
—
|
|
||
|
Non-deductible interest
|
|
—
|
|
|
—
|
|
||
|
Other
|
|
(3,044
|
)
|
|
876
|
|
||
|
|
|
|
|
|
||||
State taxes:
|
|
|
|
|
|||||
|
Current
|
|
15,194
|
|
|
32,748
|
|
||
|
Deferred
|
|
(110,517
|
)
|
|
(120,477
|
)
|
||
|
|
|
|
|
|
||||
Other items:
|
|
|
|
|
|||||
|
Federal research and development credits
|
|
(48,153
|
)
|
|
(35,550
|
)
|
||
|
Change in valuation allowance
|
|
1,479,000
|
|
|
(153,000
|
)
|
||
|
Deferred tax past year true-up's
|
|
(30,981
|
)
|
|
(99,348
|
)
|
||
|
True up - ADG NOL IRC Sec 382 limitation
|
|
—
|
|
|
817,198
|
|
||
|
Other
|
|
(955,812
|
)
|
|
30,960
|
|
||
Income tax provision
|
|
$
|
15,194
|
|
|
$
|
32,748
|
|
|
2019
|
|
2018
|
||||
Net operating loss carryforwards
|
$
|
8,299,000
|
|
|
$
|
7,206,000
|
|
R&D and ITC credit carryforwards
|
317,000
|
|
|
244,000
|
|
||
Accrued expenses and other
|
1,224,000
|
|
|
1,140,000
|
|
||
Accounts receivable
|
20,000
|
|
|
7,000
|
|
||
Inventory
|
78,000
|
|
|
73,000
|
|
||
Property, plant and equipment
|
779,000
|
|
|
568,000
|
|
||
Deferred tax assets
|
10,717,000
|
|
|
9,238,000
|
|
||
Valuation allowance
|
(10,717,000
|
)
|
|
(9,238,000
|
)
|
||
Deferred tax assets, net
|
$
|
—
|
|
|
$
|
—
|
|
•
|
issue one or more series of preferred stock;
|
•
|
determine the designations for any series of preferred stock; and
|
•
|
determine the number of shares in any series
|
|
|
•
|
whether dividends on that series of preferred stock will be cumulative and, if so, from which date;
|
•
|
the dividend rate;
|
•
|
the dividend payment date or dates;
|
•
|
any conversion provisions applicable to that series of preferred stock;
|
•
|
the liquidation preference per share of that series of preferred stock, if any;
|
•
|
any redemption or sinking fund provisions applicable to that series of preferred stock;
|
•
|
the voting rights of that series of preferred stock, if any; and
|
•
|
the terms of any other preferences or special rights applicable to that series of preferred stock.
|
1.
|
I have reviewed this Annual Report on Form 10-K of Tecogen Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
I have reviewed this Annual Report on Form 10-K of Tecogen Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
1.
|
The Annual Report on Form 10-K of the Company for the year ended December 31, 2019, or the Report, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|